|
Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug
|
Dec 2013
|
Blood
|
aplastic anemia
|
|
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
|
Sep 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
May 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Origins of myelodysplastic syndromes after aplastic anemia
|
Sep 2017
|
Blood
|
aplastic anemia
|
|
MDS-related mutations in aplastic anemia
|
Oct 2014
|
Blood
|
aplastic anemia
|
|
Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents
|
Dec 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia
|
Oct 2014
|
Blood
|
aplastic anemia
|
|
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
|
Apr 2023
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Cyclophosphamide in severe aplastic anemia?
|
Oct 2014
|
Blood
|
aplastic anemia
|
|
Clinical and biological implications of driver mutations in myelodysplastic syndromes.
|
Sep 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
